Abstract
The Tuberculosis Drug Accelerator, an experiment designed to facilitate collaboration in tuberculosis drug discovery by breaking down barriers among competing labs and institutions, has reached a 10-year landmark. We review the consortium’s achievements, advantages and limitations and advocate for the application of similar models to other diseases.
Original language | English |
---|---|
Pages (from-to) | 1333-1337 |
Number of pages | 5 |
Journal | Nature Medicine |
Volume | 27 |
Early online date | 5 Jul 2021 |
DOIs |
|
Publication status | Published - Aug 2021 |
Keywords
- Bacterial infection
- Drug development
- Drug screening
- Intellectual-property rights
- Research management
ASJC Scopus subject areas
- General Biochemistry,Genetics and Molecular Biology